Arkolith/Insider Trading/ONCY/Form 4

Parsons James T.

DirectorONCOLYTICS BIOTECH INC (ONCY) · full profile →Form 4 · filed Mar 13, 2026
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2026Buy(P)10K$1.03$10K42K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-009983) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML